These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27619513)

  • 1. "Cancer Bio-Immunotherapy in Siena": Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8-10, 2015.
    Maio M; Bertocci E; Fazio C; Chiarucci C; Cutaia O; Scala E; Giacobini G; Lofiego MF; Fonsatti E; Maccalli C; Nicolay HJ; Parmiani G;
    Cancer Immunol Immunother; 2016 Nov; 65(11):1423-1431. PubMed ID: 27619513
    [No Abstract]   [Full Text] [Related]  

  • 2. "Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014.
    Maio M; Bertocci E; Pilla L; Fazio C; Chiarucci C; Cutaia O; Fonsatti E; Maccalli C; Parmiani G;
    Cancer Immunol Immunother; 2016 Jan; 65(1):119-26. PubMed ID: 25944004
    [No Abstract]   [Full Text] [Related]  

  • 3. Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5-7, 2017.
    Maio M; Lofiego MF; Fazio C; Cannito S; Chiarucci C; Giacobini G; Valente M; Tunici P; Covre A; Russo V
    Cancer Immunol Immunother; 2019 Jan; 68(1):151-158. PubMed ID: 30094463
    [No Abstract]   [Full Text] [Related]  

  • 4. "Cancer Bio-Immunotherapy in Siena": Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17-19, 2013.
    Maio M; Nicolay HJ; Cutaia O; Fonsatti E; Parmiani G
    Cancer Immunol Immunother; 2015 Jan; 64(1):131-5. PubMed ID: 24993565
    [No Abstract]   [Full Text] [Related]  

  • 5. Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13-15, 2016.
    Russo V; Chiarucci C; Lofiego MF; Fazio C; Bertocci E; Cutaia O; Giacobini G; Lazzeri A; Lamboglia A; Altomonte M; Tunici P; Covre A; Maio M
    Cancer Immunol Immunother; 2018 Jun; 67(6):1023-1030. PubMed ID: 29058034
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy.
    Bellone M; Brevi A; Bruzzì S; Consonni M; De Santis F; Di Lullo G; Majorini MT; Pastò A; Amadori A; Bregni M; Di Nicola M; Calabrò L; Ferrucci PF; Proietti E; Colombo MP; Russo V
    Cancer Immunol Immunother; 2020 Jun; 69(6):1141-1151. PubMed ID: 32025818
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, Italy.
    Bellone M; Bregni M; Bronte V; Ugel S; Ferrucci PF; Di Nicola M; Nisticò P; Zuccolotto G; Rosato A; Russo V; Sica A; Colombo MP
    Cancer Immunol Immunother; 2022 Jul; 71(7):1777-1786. PubMed ID: 34755203
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020.
    Bellone M; Brevi A; Bronte V; Dusi S; Ferrucci PF; Nisticò P; Rosato A; Russo V; Sica A; Toietta G; Colombo MP
    Cancer Immunol Immunother; 2022 Jul; 71(7):1787-1794. PubMed ID: 35034143
    [No Abstract]   [Full Text] [Related]  

  • 9. Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19-22, 2011: New perspectives in the immunotherapy of cancer.
    Maio M; Nicolay HJ; Ascierto PA; Belardelli F; Camerini R; Colombo MP; Queirolo P; Ridolfi R; Russo V; Parisi G; Fonsatti E; Papamichail M; Parmiani G;
    Cancer Immunol Immunother; 2012 Sep; 61(9):1599-608. PubMed ID: 22736255
    [No Abstract]   [Full Text] [Related]  

  • 10. Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010.
    Maio M; Nicolay HJ; Ascierto PA; Belardelli F; Camerini R; Colombo MP; Queirolo P; Ridolfi R; Russo V; Fonsatti E; ; Parmiani G
    Cancer Immunol Immunother; 2011 Jun; 60(6):901-7. PubMed ID: 21431916
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!
    Maio M; Blank C; Necchi A; Di Giacomo AM; Ibrahim R; Lahn M; Fox BA; Bell RB; Tortora G; Eggermont AMM
    Eur J Cancer; 2021 Jul; 152():155-164. PubMed ID: 34107449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation.
    Maio M; Lahn M; Di Giacomo AM; Covre A; Calabrò L; Ibrahim R; Fox B;
    J Exp Clin Cancer Res; 2021 Jul; 40(1):240. PubMed ID: 34301276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT).
    Russo V; Amadori A; Bregni M; Calabrò L; Colombo MP; Di Nicola M; Ferrucci PF; Proietti E; Maio M; Bellone M
    Cytokine Growth Factor Rev; 2017 Aug; 36():1-3. PubMed ID: 28634022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009.
    Maio M; Nicolay HJ; Ascierto PA; Belardelli F; Camerini R; Colombo MP; Queirolo P; Ridolfi R; Russo V; Fonsatti E; Parmiani G;
    Cancer Immunol Immunother; 2010 Dec; 59(12):1895-901. PubMed ID: 20204388
    [No Abstract]   [Full Text] [Related]  

  • 15. Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16-18 October 2008.
    Maio M; Nicolay HJ; Ascierto PA; Belardelli F; Camerini R; Colombo MP; Queirolo P; Ridolfi R; Russo V; Fonsatti E; Parmiani G;
    Cancer Immunol Immunother; 2010 Jun; 59(6):963-9. PubMed ID: 19330329
    [No Abstract]   [Full Text] [Related]  

  • 16. The Italian Network for Tumor Biotherapy (NIBIT). Sharing visions, goals and efforts at European level.
    Maio M; Fonsatti E; Burigo A; Parmiani G
    Tumori; 2008; 94(2):179-81. PubMed ID: 18564604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology.
    Di Giacomo AM; Covre A; Giacobini G; Ibrahim R; Lyman J; Natali PG; Maio M
    Cancer Immunol Immunother; 2019 Jan; 68(1):143-150. PubMed ID: 30564888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012.
    Maio M; Nicolay HJ; Ascierto PA; Belardelli F; Camerini R; Colombo MP; Queirolo P; Ridolfi R; Russo V; Parisi G; Cutaia O; Fonsatti E; Parmiani G
    Cancer Immunol Immunother; 2013 Dec; 62(12):1851-8. PubMed ID: 24190546
    [No Abstract]   [Full Text] [Related]  

  • 19. Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy.
    Maio M; Coukos G; Ferrone S; Fox BA; Fridman WH; Garcia PL; Lahn M; Provendier O; Russo V; Rüttinger D; Shalabi A; Trajanoski Z; Viallet J; Wolchok JD; Ibrahim R
    Cancer Immunol Immunother; 2019 Jan; 68(1):1-9. PubMed ID: 30564889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer immunity and immunotherapy beyond COVID-19.
    Bellone M; Brevi A; Bronte V; Dusi S; Ferrucci PF; Nisticò P; Rosato A; Russo V; Sica A; Toietta G; Colombo MP
    Cancer Immunol Immunother; 2023 Jul; 72(7):2541-2548. PubMed ID: 36995489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.